Seoul, South Korea

Hyun-Hee Park

USPTO Granted Patents = 39 

 

Average Co-Inventor Count = 7.5

ph-index = 4

Forward Citations = 88(Granted Patents)


Location History:

  • Seoul, KR (2012 - 2024)
  • Seongnam-si, KR (2016 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
39 patents (USPTO):

Title: Innovations of Hyun-Hee Park: Anti-Inflammatory Peptides and Their Applications

Introduction: Hyun-Hee Park, a prolific inventor based in Seoul, South Korea, holds an impressive 39 patents to his name. His innovations are primarily centered around the development of anti-inflammatory peptides, showcasing significant potential in both pharmaceutical and cosmetic applications.

Latest Patents: Among his latest innovations, Hyun-Hee Park has developed a peptide with remarkable anti-inflammatory properties. This peptide includes at least one amino acid sequence from SEQ ID NO: 2 to SEQ ID NO: 179, with over 80% homology to these sequences. The peptides or their fragments demonstrate outstanding efficacy in suppressing inflammation and in prophylactic applications. His compositions can be employed not only as anti-inflammatory pharmaceutical formulations but also as cosmetic solutions for treating and preventing various inflammatory diseases. Moreover, he has introduced a method for treating autoimmune diseases by administering an isolated peptide from SEQ ID NO: 1, further emphasizing his contributions to the field.

Career Highlights: Throughout his career, Hyun-Hee Park has worked with prestigious organizations, including Samsung Electronics Co., Ltd. and Gemvax & Kael Co., Ltd., where he has significantly advanced research in the biomedical field. His work has paved the way for new therapeutic approaches, particularly in combating inflammatory conditions.

Collaborations: Hyun-Hee Park has collaborated with notable professionals such as Sang Jae Kim and Kyung Hee Kim. These partnerships have facilitated the development of innovative solutions and have contributed to the success of his research endeavors.

Conclusion: Hyun-Hee Park's work in the realm of anti-inflammatory peptides represents a significant advancement in biomedical innovation. His patents emphasize the importance of his contributions to both the treatment of inflammatory diseases and the cosmetic industry. As research in this field progresses, Hyun-Hee Park continues to be a key player in driving impactful solutions and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…